PIK3CD and acute myeloid leukemia: Indeed among the first isoform-specific PI3K inhibitors developed, the specific p110δ inhibitor IC87114 was used to demonstrate that p110δ could play a role in the pathophysiology of acute myeloid leukemia (Sadhu et al., 2003).